About ZYFEXINE-S 1.5GM INJECTION
ZYFEXINE-S 1.5GM INJECTION, an elite offering from Zydus Healthcare Limited, stands as a monumental Advance in combating bacterial infections. This first-string, venerable formulation combines Ceftriaxone 1000mg and Sulbactam 500mg, delivering highlighted efficacy as a third-generation cephalosporin with a beta-lactamase inhibitor. For optimal results, the powder is reconstituted with sterile water before intravenous or intramuscular administration. Designed for adults, ZYFEXINE-S is recommended for respiratory, urinary, skin, soft tissue, abdominal, and gynecological infections, making it a trusted choice found in modern clinical practice.
ZYFEXINE-S 1.5GM INJECTION: Distinguished Application and Features
ZYFEXINE-S 1.5GM INJECTION is administered via intravenous (IV) or intramuscular (IM) routes after reconstitution with sterile water, as supplied. Its key advantage lies in its combination of ceftriaxone and sulbactam, enhancing spectrum and overcoming resistance. The product features a white to off-white powder form, with immediate stability post-reconstitution. The antibiotic's notable efficacy in treating multiple bacterial infections highlights its suitability for adult patients requiring reliable, prescription-based therapy.
ZYFEXINE-S 1.5GM INJECTION: Export Markets, Sample Policy, and Delivery
ZYFEXINE-S 1.5GM INJECTION is supplied globally, with India as the origin of manufacturing. Export markets are prioritized based on demand and regulatory flexibility. Samples may be supplied as per policy, subject to charge where applicable. Delivery timelines depend on destination and order quantity, with competitive list prices and professional handling ensuring efficient distribution. Each supply comes with clear packaging and batch details for tracking and quality assurance.
FAQ's of ZYFEXINE-S 1.5GM INJECTION:
Q: How should ZYFEXINE-S 1.5GM INJECTION be administered?
A: ZYFEXINE-S 1.5GM INJECTION is administered either intravenously or intramuscularly after reconstituting the powder with the provided sterile water for injection, according to the physician's instructions.
Q: What are the core benefits of using ZYFEXINE-S 1.5GM INJECTION?
A: The main benefit is its powerful combination of ceftriaxone and sulbactam, delivering broad-spectrum antibacterial action and increased effectiveness against resistant bacterial strains.
Q: When should the injection be used after reconstitution?
A: For optimal efficacy and safety, ZYFEXINE-S 1.5GM INJECTION should be used immediately after reconstitution.
Q: What conditions is ZYFEXINE-S 1.5GM INJECTION recommended for?
A: This injection is suitable for treating respiratory tract, urinary tract, skin and soft tissue, abdominal, and gynecological infections caused by susceptible bacteria.
Q: Where can information regarding batch number and barcode be found?
A: Barcode and batch information are detailed on the label of each vial for transparency and traceability.
Q: What precautions should be taken before using ZYFEXINE-S 1.5GM INJECTION?
A: It should not be used in individuals with known hypersensitivity to cephalosporins or sulbactam, and only under a physician's guidance.